Immunovant Inc (IMVT)
NASDAQ
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current IMVT market cap is 3.19B. The company's latest EPS is USD -1.5268 and P/E is -12.30.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -61.55M | -80.88M | -94.28M | -115.74M | -114.3M |
| Net Income | -51.42M | -75.32M | -87.15M | -109.12M | -111.12M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -66.08M | -108.12M | -156.03M | -218.28M | -282.71M |
| Net Income | -66.39M | -107.43M | -156.73M | -210.96M | -259.34M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 711.45M | 666.37M | 589.68M | 515.71M | 420.93M |
| Total Liabilities | 32.1M | 48.61M | 45.02M | 66.65M | 68.32M |
| Total Equity | 679.34M | 617.76M | 544.66M | 449.05M | 352.62M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 109.39M | 412.49M | 515.56M | 405.84M | 666.37M |
| Total Liabilities | 15.32M | 21.01M | 45.74M | 43.34M | 48.61M |
| Total Equity | 94.07M | 391.48M | 469.83M | 362.49M | 617.76M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -154.53M | -214.23M | -76.2M | -164.85M | -265.24M |
| Investing | -210k | -360k | -182k | -378k | -558k |
| Financing | 470.88M | 472.43M | 686k | 1.42M | 3.88M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -53.36M | -83.33M | -106.11M | -188.19M | -214.23M |
| Investing | -31k | -210k | -254k | -197k | -360k |
| Financing | 146.97M | 383.11M | 200.13M | 70.89M | 472.43M |
| Market Cap | 3.19B |
| Price to Earnings Ratio | -12.30 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 5.02 |
| Price to Book Ratio | 5.16 |
| Dividend Yield | - |
| Shares Outstanding | 169.86M |
| Average Volume (1 week) | 1.14M |
| Average Volume (1 Month) | 1.09M |
| 52 Week Change | -42.11% |
| 52 Week High | 35.97 |
| 52 Week Low | 17.65 |
| Spread (Intraday) | 1.88 (9.43%) |
| Company Name | Immunovant Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.immunovant.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
